People

Richard Goss joined Tekla in2018 as vice president of research. The2023 fund filing documents prior Leerink Partners large-pharmaceutical/biotechnology equity research and Datamonitor healthcare analysis, and his move to abrdn as investment director inOctober2023. This is a historical manager affiliation, distinct from personal equity allocations.

Roles

Tekla Capital Management

Vice President, Research — historical

2023-10-27